Triple
T3849413
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Center for Drug Evaluation and Research |
E85252
|
entity |
| Predicate | oversees |
P46
|
FINISHED |
| Object |
Office of Translational Sciences
The Office of Translational Sciences is a scientific office within the U.S. Food and Drug Administration that advances the translation of biomedical research into safe and effective drug therapies through regulatory science, research, and policy development.
|
E392787
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Office of Translational Sciences | Statement: [Center for Drug Evaluation and Research, oversees, Office of Translational Sciences]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Office of Translational Sciences Context triple: [Center for Drug Evaluation and Research, oversees, Office of Translational Sciences]
-
A.
National Center for Advancing Translational Sciences
The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
-
B.
Division of Extramural Research
The Division of Extramural Research is a branch of the National Human Genome Research Institute that oversees and funds genome-related research conducted outside the institute.
-
C.
Center for Scientific Review
The Center for Scientific Review is the National Institutes of Health component responsible for overseeing the peer review of most grant applications to ensure scientific merit and integrity in funding decisions.
-
D.
Center for Health and Biosciences
The Center for Health and Biosciences is a research and policy institute focused on health care, biomedical innovation, and related public policy issues.
-
E.
Division of Intramural Research
The Division of Intramural Research is the National Heart, Lung, and Blood Institute’s in-house research arm that conducts basic, translational, and clinical studies on cardiovascular, pulmonary, and blood-related diseases.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Office of Translational Sciences Triple: [Center for Drug Evaluation and Research, oversees, Office of Translational Sciences]
Generated description
The Office of Translational Sciences is a scientific office within the U.S. Food and Drug Administration that advances the translation of biomedical research into safe and effective drug therapies through regulatory science, research, and policy development.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Office of Translational Sciences Target entity description: The Office of Translational Sciences is a scientific office within the U.S. Food and Drug Administration that advances the translation of biomedical research into safe and effective drug therapies through regulatory science, research, and policy development.
-
A.
National Center for Advancing Translational Sciences
The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
-
B.
Division of Extramural Research
The Division of Extramural Research is a branch of the National Human Genome Research Institute that oversees and funds genome-related research conducted outside the institute.
-
C.
Center for Scientific Review
The Center for Scientific Review is the National Institutes of Health component responsible for overseeing the peer review of most grant applications to ensure scientific merit and integrity in funding decisions.
-
D.
Center for Health and Biosciences
The Center for Health and Biosciences is a research and policy institute focused on health care, biomedical innovation, and related public policy issues.
-
E.
Division of Intramural Research
The Division of Intramural Research is the National Heart, Lung, and Blood Institute’s in-house research arm that conducts basic, translational, and clinical studies on cardiovascular, pulmonary, and blood-related diseases.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69aed936de1c81908f91bed80f70abb2 |
completed | March 9, 2026, 2:29 p.m. |
| NER | Named-entity recognition | batch_69aeebcde86081908cf3840ae002acfa |
completed | March 9, 2026, 3:48 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69b504172d58819089d19f5cb7b803ec |
completed | March 14, 2026, 6:45 a.m. |
| NEDg | Description generation | batch_69b504f32da48190a561cc72f0c4e827 |
completed | March 14, 2026, 6:49 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69b5064192a48190a0f95dee872437e0 |
completed | March 14, 2026, 6:54 a.m. |
Created at: March 9, 2026, 3:19 p.m.